JOURNAL ARTICLE
REVIEW
Add like
Add dislike
Add to saved papers

Women, Surgeons, and the Innovation Pipeline.

The paucity of gender diversity in the biotech and medical/surgical technology fields remains a persistent challenge. Over the course of history, advancements have been made; however, women remain underrepresented in these sectors from the entry level to the leadership and corporate positions. Similarly, there is a notable lack of women-led startup teams obtaining funding from venture capitalists and fewer women-led teams submitting and securing patents. We will discuss current data surrounding the lack of gender diversity in these fields, explore parallels specifically between the lack of women in surgical specialties and science, technology, engineering, and mathematics (STEM) pathways, and how this translates to the lack of women in the surgical and medical technology industry. We will also offer examples of the real-world ramifications of product development by teams not representative of the population. Lastly, we will offer recommendations and action items for companies, STEM educators, individuals, and allies that will continue to aid in improving gender diversity in the industry.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app